论文部分内容阅读
目的 进行一项前瞻性随机单盲试验 ,以评估和对比头孢曲松 (ｃｅｆｔｒｉａｘｏｎｅ)一次性肌肉注射与口服ＳＭＺＣｏ治疗急性中耳炎 (ＡＯＭ )的疗效。方法 将年龄 3个月～ 3岁 ,诊断为ＡＯＭ(具有急性病体征和中耳渗出液的证据 )的患儿随机分组 ,分别给予头孢曲松 (最大剂
Objective To conduct a prospective, randomized, single-blind trial to assess and compare the efficacy of ceftriaxone administered intramuscularly with oral SMZCo for acute otitis media (AOM). METHODS: Children aged 3 months to 3 years and diagnosed with AOM (evidence of acute disease signs and evidence of middle ear exudate) were randomized to ceftriaxone (maximal